Buy & Sell Heron Therapeutics Inc (HRTX) – Heron Therapeutics Inc Price Today
Aura AI Summary
Key Stats
- $75.73MMarket Cap
- HealthSector
- -69.46%3M Drawdown
- $173.63MEnterprise Value
- -Dividend Yield
- 36% Buy | 64% SellTrading Activity
- 19 daysTypical Hold Time
Heron Therapeutics Inc (HRTX) is currently valued at a market capitalization of $75.73M, with an enterprise value of $173.63M. Over the past 52 weeks, Heron Therapeutics Inc has traded between a low of $0.4 and a high of $2.23, highlighting its annual price range. Over the past three months, Heron Therapeutics Inc has recorded a drawdown of -69.46%, reflecting recent price volatility. On average, investors hold Heron Therapeutics Inc for approximately 19 days, indicating typical investor behavior on the platform.
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Most Recent News
AI chip stocks drop sharply after Broadcom's Q3 revenue guide misses expectations, dragging sector down.
In June 2026, major semiconductor stocks NVIDIA, AMD, and Broadcom saw significant price declines after Broadcom's Q3 AI revenue guidance of $16 billion fell short of analyst expectations near $17.2 billion. This caused the PHLX chip index to drop 10...

EU policies boost ArcelorMittal, easing steel market pressures amid Middle East peace hopes
The EU is introducing policies favoring domestic steel producers, benefiting companies like ArcelorMittal that earn significant revenue in Europe. While the company also profits from US trade protections, overall margins have been squeezed due to Eur...

Nebius Q1 2026 revenue jumps 6.8x to $399M, driven by AI Cloud growth and new US projects.
Nebius reported a strong Q1 2026 with revenue increasing 6.8 times to $399 million, primarily fueled by its AI Cloud business which now accounts for about 98% of total revenue. The company sees strong demand momentum, highlighted by a record sales pi...
